Literature DB >> 31733690

Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology.

David K Simon1, Caroline M Tanner2, Patrik Brundin3.   

Abstract

Parkinson disease is a complex, age-related, neurodegenerative disease associated with dopamine deficiency and both motor and nonmotor deficits. Many environmental and genetic factors influence Parkinson disease risk, with different factors predominating in different patients. These factors converge on specific pathways, including mitochondrial dysfunction, oxidative stress, protein aggregation, impaired autophagy, and neuroinflammation. Ultimately, treatment of Parkinson disease may focus on targeted therapies for pathophysiologically defined subtypes of Parkinson disease patients.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epidemiology; Genetics; Mitochondrial; Neuroprotection; Parkinson disease; Pathology; Pathophysiology; Synuclein

Mesh:

Year:  2019        PMID: 31733690      PMCID: PMC6905381          DOI: 10.1016/j.cger.2019.08.002

Source DB:  PubMed          Journal:  Clin Geriatr Med        ISSN: 0749-0690            Impact factor:   3.076


  69 in total

1.  alpha-Synuclein locus triplication causes Parkinson's disease.

Authors:  A B Singleton; M Farrer; J Johnson; A Singleton; S Hague; J Kachergus; M Hulihan; T Peuralinna; A Dutra; R Nussbaum; S Lincoln; A Crawley; M Hanson; D Maraganore; C Adler; M R Cookson; M Muenter; M Baptista; D Miller; J Blancato; J Hardy; K Gwinn-Hardy
Journal:  Science       Date:  2003-10-31       Impact factor: 47.728

Review 2.  Cell Biology and Pathophysiology of α-Synuclein.

Authors:  Jacqueline Burré; Manu Sharma; Thomas C Südhof
Journal:  Cold Spring Harb Perspect Med       Date:  2018-03-01       Impact factor: 6.915

3.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

Authors:  M H Polymeropoulos; C Lavedan; E Leroy; S E Ide; A Dehejia; A Dutra; B Pike; H Root; J Rubenstein; R Boyer; E S Stenroos; S Chandrasekharappa; A Athanassiadou; T Papapetropoulos; W G Johnson; A M Lazzarini; R C Duvoisin; G Di Iorio; L I Golbe; R L Nussbaum
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

4.  Mortality in Parkinson's disease: a 38-year follow-up study.

Authors:  Bernadette Pinter; Anja Diem-Zangerl; Gregor Karl Wenning; Christoph Scherfler; Willi Oberaigner; Klaus Seppi; Werner Poewe
Journal:  Mov Disord       Date:  2014-12-01       Impact factor: 10.338

5.  Association of coffee and caffeine intake with the risk of Parkinson disease.

Authors:  G W Ross; R D Abbott; H Petrovitch; D M Morens; A Grandinetti; K H Tung; C M Tanner; K H Masaki; P L Blanchette; J D Curb; J S Popper; L R White
Journal:  JAMA       Date:  2000 May 24-31       Impact factor: 56.272

Review 6.  Targeting α-Synuclein in Parkinson's Disease: Progress Towards the Development of Disease-Modifying Therapeutics.

Authors:  Daniel Savitt; Joseph Jankovic
Journal:  Drugs       Date:  2019-06       Impact factor: 9.546

Review 7.  Small-Molecule Inhibitors of LRRK2.

Authors:  John M Hatcher; Hwan Geun Choi; Dario R Alessi; Nathanael S Gray
Journal:  Adv Neurobiol       Date:  2017

8.  Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism.

Authors:  Vincenzo Bonifati; Patrizia Rizzu; Marijke J van Baren; Onno Schaap; Guido J Breedveld; Elmar Krieger; Marieke C J Dekker; Ferdinando Squitieri; Pablo Ibanez; Marijke Joosse; Jeroen W van Dongen; Nicola Vanacore; John C van Swieten; Alexis Brice; Giuseppe Meco; Cornelia M van Duijn; Ben A Oostra; Peter Heutink
Journal:  Science       Date:  2002-11-21       Impact factor: 47.728

9.  Dose-dependent progression of parkinsonism in manganese-exposed welders.

Authors:  Brad A Racette; Susan Searles Nielsen; Susan R Criswell; Lianne Sheppard; Noah Seixas; Mark N Warden; Harvey Checkoway
Journal:  Neurology       Date:  2016-12-28       Impact factor: 9.910

10.  Genetic basis of Parkinson's disease: inheritance, penetrance, and expression.

Authors:  Claudia Schulte; Thomas Gasser
Journal:  Appl Clin Genet       Date:  2011-06-01
View more
  98 in total

Review 1.  MicroRNAs in the pathophysiology of Alzheimer's disease and Parkinson's disease: an overview.

Authors:  Mohammad Rafi Khezri; Keyvan Yousefi; Naime Majidi Zolbanin; Morteza Ghasemnejad-Berenji
Journal:  Mol Neurobiol       Date:  2022-01-09       Impact factor: 5.590

2.  High-quality nursing intervention can improve negative emotions, quality of life and activity of daily living of elderly patients with Parkinson's disease.

Authors:  Yihui Gui; Youya Zhou
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

Review 3.  Endosomal Trafficking in Alzheimer's Disease, Parkinson's Disease, and Neuronal Ceroid Lipofuscinosis.

Authors:  Yasir H Qureshi; Penelope Baez; Christiane Reitz
Journal:  Mol Cell Biol       Date:  2020-09-14       Impact factor: 4.272

4.  Overdosing on iron: Elevated iron and degenerative brain disorders.

Authors:  Santosh R D'Mello; Mark C Kindy
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-02

5.  Inhibition of NADPH oxidase within midbrain periaqueductal gray decreases pain sensitivity in Parkinson's disease via GABAergic signaling pathway.

Authors:  W Zhang; L Sun; X Yang; R Wang; H Wang
Journal:  Physiol Res       Date:  2020-06-25       Impact factor: 1.881

Review 6.  Meta-Analysis of Cognition in Parkinson's Disease Mild Cognitive Impairment and Dementia Progression.

Authors:  Elizabeth R Wallace; Suzanne C Segerstrom; Craig G van Horne; Frederick A Schmitt; Lisa M Koehl
Journal:  Neuropsychol Rev       Date:  2021-04-16       Impact factor: 7.444

Review 7.  Role of Microgliosis and NLRP3 Inflammasome in Parkinson's Disease Pathogenesis and Therapy.

Authors:  Fillipe M de Araújo; Lorena Cuenca-Bermejo; Emiliano Fernández-Villalba; Silvia L Costa; Victor Diogenes A Silva; Maria Trinidad Herrero
Journal:  Cell Mol Neurobiol       Date:  2021-01-02       Impact factor: 5.046

Review 8.  Novel Pharmacotherapies in Parkinson's Disease.

Authors:  Yousef Tizabi; Bruk Getachew; Michael Aschner
Journal:  Neurotox Res       Date:  2021-05-18       Impact factor: 3.911

Review 9.  The Renin-Angiotensin System Modulates Dopaminergic Neurotransmission: A New Player on the Scene.

Authors:  Tamara Kobiec; Matilde Otero-Losada; Guenson Chevalier; Lucas Udovin; Sofía Bordet; Camila Menéndez-Maissonave; Francisco Capani; Santiago Pérez-Lloret
Journal:  Front Synaptic Neurosci       Date:  2021-04-22

Review 10.  Approaches to Disease Modification for Parkinson's Disease: Clinical Trials and Lessons Learned.

Authors:  Albert Y Hung; Michael A Schwarzschild
Journal:  Neurotherapeutics       Date:  2020-11-17       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.